ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.13M | -53.36M | -27.76M | -26.31M | -23.60M |
| Total Depreciation and Amortization | 6.53M | 6.64M | 7.66M | 7.06M | 6.81M |
| Total Amortization of Deferred Charges | 1.72M | 1.49M | 1.03M | 463.00K | 252.00K |
| Total Other Non-Cash Items | 5.73M | 12.81M | 2.82M | 3.17M | 3.90M |
| Change in Net Operating Assets | 13.37M | 14.89M | 1.51M | 250.00K | -4.87M |
| Cash from Operations | -15.78M | -17.54M | -14.74M | -15.37M | -17.50M |
| Capital Expenditure | -39.00K | -906.00K | -1.31M | -1.80M | -2.43M |
| Sale of Property, Plant, and Equipment | 282.00K | 229.00K | 229.00K | 150.00K | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 597.00K | 3.10M | 2.23M | 3.23M | 5.11M |
| Cash from Investing | 840.00K | 2.42M | 1.20M | 1.63M | 2.72M |
| Total Debt Issued | 7.61M | 9.86M | 8.33M | 3.87M | 2.46M |
| Total Debt Repaid | -5.57M | -4.25M | -2.50M | -894.00K | -185.00K |
| Issuance of Common Stock | 10.87M | 7.59M | 4.62M | 5.82M | 1.20M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -47.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 947.00K | 978.00K | -4.00K | -4.00K | -4.00K |
| Cash from Financing | 13.85M | 14.19M | 13.37M | 11.72M | 6.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.09M | -931.00K | -169.00K | -2.02M | -8.44M |